Clinical Trial Update: A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain. [Phase 3]

View source ↗

Summary

Phase 3 study assessing the effectiveness and safety of sustained-release hydromorphone for chronic noncancer pain; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noncancer Pain

Drugs mentioned

• Hydromorphone sustained-release (ER) (hydromorphone)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2012-12-24